Transplant rejection - 1 News by Thermo Fisher Scientific

Transplant rejection - 1 News by Thermo Fisher Scientific

image description

Verici DX reaches a global licensing and commercialisation agreement with Thermo Fisher Scientific

Agreement grants rights to further develop an assay for pre-transplant prognostic testing

20-Nov-2023 - Verici Dx plc, a developer of advanced clinical diagnostics for organ transplant, announced that it has signed an exclusive global licensing agreement with Thermo Fisher Scientific to further develop an assay for pre-transplant prognostic testing for risk of early kidney rejection. The exclusive ...

transplant rejection assays clinical diagnostics
Haven't found the right news yet?

The analytica-world.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 7,464 lab and analytics news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now